Angelman Syndrome Clinical Severity and Genetic Subtype Assessment
Assesses Angelman syndrome severity using UBE3A genetic mechanism (deletion vs UPD vs ImprintingCentreMutation vs UBE3A mutation), seizure burden, motor/language milestones, and EEG pattern scoring.